European Medicines Agency appeals Brexit “frustration” ruling

By Mitchell Labiak2019-04-17T13:23:00

The European Medicines Agency (EMA) has appealed the High Court’s ruling that Brexit did not amount to the legal “frustration” of its £500m, 25-year lease with Canary Wharf Group.

The agency was given leave to appeal last month and submitted its appeal just before its deadline on Monday 15 April.

This content is only available to registered users

You must be logged in to continue

Would you like to read more?

Try Property Week For Free to finish this article.

Unlimited access to Property Week
Breaking news, comment and analysis from industry experts as it happens
Choose from our portfolio of email newsletters

To access this article TRY FOR FREE NOW

Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.

Registered users and subscribers SIGN IN here to continue